Penn Capital Management Company, LLC

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1158202 PHILADELPHIA, PA

Position in MIRM

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$34,993,861

+$11,273,726 QoQ

Shares Held

298,914

+16.4% QoQ

Ownership

0.460%

of shares outstanding

% of Portfolio

2.23%

of 13F equity value

Holder Rank

#57

of 326 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Penn Capital Management Company, LLC holds $100,162,194 across 7 Biotechnology names. MIRM ranks #1 (34.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc. This page	298,914	$34,993,861
2	LGND	Ligand Pharmaceuticals Inc	100,337	$31,715,522
3	TGTX	Tg Therapeutics, Inc.	536,067	$29,451,520
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,811	$1,509,366
5	TVTX	Travere Therapeutics, Inc.	14,968	$850,332
6	PVLA	Palvella Therapeutics, Inc.	5,506	$841,426
7	NRIX	Nurix Therapeutics, Inc.	32,983	$800,167

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,993,861	298,914	+16.4%	Shares	Sole	2026-07-30
2026-03-31	$23,720,135	256,767	-8.9%	Shares	Sole	2026-05-07
2025-12-31	$22,268,702	281,918	-8.5%	Shares	Sole	2026-02-09
2025-09-30	$22,578,820	307,991	-10.0%	Shares	Sole	2025-11-24
2025-06-30	$17,417,407	342,256	-8.4%	Shares	Sole	2025-08-14
2025-03-31	$16,827,030	373,519	+34.2%	Shares	Sole	2025-05-14
2024-12-31	$11,512,956	278,427	-10.0%	Shares	Sole	2025-02-14
2024-09-30	$12,060,516	309,244	+28.2%	Shares	Sole	2024-11-14
2024-06-30	$8,244,952	241,151	-1.8%	Shares	Sole	2024-08-13
2024-03-31	$6,171,883	245,696	-0.0%	Shares	Sole	2024-05-15
2023-12-31	$7,253,890	245,728	-0.1%	Shares	Sole	2024-02-14
2023-09-30	$7,772,652	245,970	+2.8%	Shares	Sole	2023-11-15
2023-06-30	$6,190,018	239,274	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.